Discontinued — last reported Q2 '24
Current Liabilities
Accrued Manufacturing Costs
Eli Lilly Accrued Manufacturing Costs decreased by 42.8% to $1.36B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.0%, from $1.11B to $1.36B. Over 5 years (FY 2020 to FY 2025), Accrued Manufacturing Costs shows an upward trend with a 19.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2015
Last reportedQ2 2024
Metric ID:
accrued_manufacturing_costsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $755.50M | $836.60M | $958.10M | $693.10M | $835.80M | $984.10M | $1.06B | $739.70M | $867.70M | $1.23B | $1.65B | $844.20M | $1.17B | $1.70B | $2.09B | $1.11B | $1.30B | $1.97B | $2.38B | $1.36B |
| QoQ Change | — | +10.7% | +14.5% | -27.7% | +20.6% | +17.7% | +7.7% | -30.2% | +17.3% | +42.1% | +33.8% | -48.8% | +38.4% | +45.8% | +22.9% | -46.8% | +17.0% | +50.9% | +20.8% | -42.8% |
| YoY Change | — | — | — | — | +10.6% | +17.6% | +10.6% | +6.7% | +3.8% | +25.3% | +55.7% | +14.1% | +34.6% | +38.1% | +26.9% | +31.9% | +11.5% | +15.4% | +13.4% | +22.0% |
Range$693.10M – $2.38B
CAGR+13.2%
Avg YoY Growth+21.2%
Median YoY Growth+16.5%
Accrued Manufacturing Costs at Other Companies
Frequently Asked Questions
- What is Eli Lilly's accrued manufacturing costs?
- Eli Lilly (LLY) reported accrued manufacturing costs of $1.36B in Q1 2026.
- How has Eli Lilly's accrued manufacturing costs changed year-over-year?
- Eli Lilly's accrued manufacturing costs increased by 22.0% year-over-year, from $1.11B to $1.36B.
- What is the long-term trend for Eli Lilly's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Eli Lilly's accrued manufacturing costs has grown at a 19.0% compound annual growth rate (CAGR), from $997.20M to $2.38B.